Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Hakushindo Pharmaceutical Co., Ltd." found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Hakushindo Pharmaceutical Co., Ltd. for you to read. Along with our medical data and news we also list Hakushindo Pharmaceutical Co., Ltd. Clinical Trials, which are updated daily. BioPortfolio also has a large database of Hakushindo Pharmaceutical Co., Ltd. Companies for you to search.
Privately-held Swedish pharmaceutical company Lobsor Pharmaceuticals AB is eying the U.S. market for a potential treatment for neurodegenerative diseases such as Parkinson’s disease.
The pharmaceutical company is manufacturing an antiretroviral therapy for drug-resistant HIV patients
A study has revealed an in vitro method that could screen a number of various compounds to identify ones that would make swallowing medicine easier... The post Developing easy-to-swallow medicine for children appeared first on European Pharmaceutical Review.
S3 Process is using BioPure BioClamp and BioPure silicone gasket technology on its new PuroVaso containers for the effective handling of powders and tablets in life science applications... The post
PDM Healthcare GPO members to have access to traditional and Rapid Credit Program Box and Ship services Pharma Logistics and PDM Healthcare jointly announce the offering of Pharma Logistics reverse pharmaceutical distribution services. Pharma Logistics’ services are focused on compliance, convenience and affordability, while offering insight...
SHANGHAI, March 20, 2019 /PRNewswire/ -- Continued innovation and increased investment will become the theme of Chinese pharmaceutical enterprises' development in 2019 with the continuous advancement of generic drug consistency evaluation, acceleration of review and approval, and implementation of procurement with target quantity. With such a background, improving pharmaceutical machinery and pack...
GlaxoSmithKline (GSK) oncology subsidiary Tesaro has unveiled promising data from its Phase I/II Garnet study evaluating dostarlimab as a monotherapy...Read More... The post GSK announces positive data for endometrial cancer drug dostarlimab appeared first on Pharmaceutical Technology.
Hepatitis C is a viral infection that can have serious and potentially life-threatening consequences to the liver if left untreated....Read More... The post Hepatitis C infection: does gender play a role? appeared first on Pharmaceutical Technology.
Genzada Pharmaceuticals USA Inc. (Genzada), a subsidiary of Ionics Life Sciences Limited, announced today that the first patient enrolled in its Phase 1 clinical trial for the oral therapeutic GZ17-6.02 received the first dose this week at
Counseling and resources available free-of-charge to local community Magellan Health, Inc. (NASDAQ: MGLN) today announced that it will open a free 24-hour crisis line for all individuals impacted by the flooding in Nebraska. The toll-free number to access free, confidential counseling services is 1-800-327-7451. Magellan...
The Israeli pharmaceutical company is closing its tablets factory and inhalers factories on the properties this year.
Fishawack, a leading independent healthcare communications specialist, is excited to announce its acquisition of Dudnyk, the Philadelphia-based healthcare communications agency. Dudnyk is an award-winning, full-service agency that specializes in creating insight-driven, authentic brand experiences that unite specialty physicians and their patients. They le...
Group Aims to Bring Disease-Associated Biomarker Through FDA’s Drug Development Tools Qualification Program The ERP Biomarker Qualification Consortium was launched today by pharmaceutical industry members with the goal of qualifying event-related potential (ERP) biomarkers to aid the development of new investigational therapies for people with schizo...
News outlets report on stories related to pharmaceutical pricing.
On the back of positive results from their Phase III trial of darolutamide in men with high-risk nonmetastatic castration-resistant prostate...Read More... The post Bayer, Orion seek approval for prostate cancer drug amid stiff competition appeared first on Pharmaceutical Technology.
The US Food and Drug Administration (FDA) dealt Sanofi’s dengue fever vaccine a serious blow when an advisory committee failed...Read More... The post FDA advisory committee fails to fully endorse Sanofi’s Dengvaxia appeared first on Pharmaceutical Technology.
Yongchang Qiu, Ph.D., Named Vice President, Preclinical Development; Ryan Tyler, Ph.D., Named Senior Director, Preclinical Research; Niels Svenstrup, Ph.D., Promoted to Senior Vice President, Development Heather Halem, Ph.D., Named a Cydan Fellow Cydan, an orphan drug accelerator dedicated to creating therapies that improve the lives of p...
This study will evaluate the ready-to-use, room-temperature stable liquid glucagon as a pre-treatment to prevent exercise-induced hypoglycemia... The post Ready-to-use glucagon for exercise-induced hypoglycaemia appeared first on European Pharmaceutical Review.
Sterile products are designed to be injected or infused directly into the bloodstream, bypassing the body’s natural defence mechanisms. Both...Read More... The post Risk management, sterile pharmaceutical products and a post-Brexit UK pharma industry appeared first on Pharmaceutical Technology.
A group of researchers at the Cambridge Institute for Medical Research found that the epigenetic protein delayed the development of AML. However, the epigenetic protein was found to The post Study suggests epigenetic protein as new therapeutic target in AML appeared first on Pharmaceutical Business review.
NewsThe global antifungal drugs market size is expected to reach USD 12.7 billion by 2025, progressing at a CAGR of 1.5 percent during the forecast period.
Japanese drugmaker Ayumi Pharmaceutical Corp has been purchased by Blackstone Group in what is reportedly a $1 billion deal. -More-
- Molsheim, France center supports pharmaceutical and biotechnology customers from pre-clinical through full-scale production in non-GMP environment - Hands-on customer access to Merck's Life Scie...
The alliance has notified health authorities and trial investigators of the decision to discontinue the trial. The decision was based on several emerging factors since the trial’s initiation, The post Merck KGaA, Pfizer discontinue phase III JAVELIN ovarian PARP 100 trial appeared first on Pharmaceutical Business review.
Arecor Limited, the specialty pharmaceutical company leveraging its innovative and proprietary formulation technology to develop superior treatments for a range of disease areas, including diabetes, today announces that a Phase I Clinical Trial Application (“CTA”) for product candidate AT247 has been approved by the Bundesamt für Sicherheit im Gesundheitswesen (BASG), the Austrian Fed...